These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 19092675)

  • 1. The influence of race and language on chronic hepatitis C virus infection management.
    Giordano C; Cooper C
    Eur J Gastroenterol Hepatol; 2009 Feb; 21(2):131-6. PubMed ID: 19092675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of immigration status, race and language barriers on chronic hepatitis C virus infection management and treatment outcomes.
    Giordano C; Druyts EF; Garber G; Cooper C
    Eur J Gastroenterol Hepatol; 2009 Sep; 21(9):963-8. PubMed ID: 19318966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of chronic hepatitis C virus infection - Dutch national guidelines.
    de Bruijne J; Buster EH; Gelderblom HC; Brouwer JT; de Knegt RJ; van Erpecum KJ; Schalm SW; Bakker CM; Zaaijer HL; Janssen HL; Reesink HW;
    Neth J Med; 2008; 66(7):311-22. PubMed ID: 18663263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in the treatment of hepatitis C.
    Lawrence SP
    Adv Intern Med; 2000; 45():65-105. PubMed ID: 10635046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults.
    Rockstroh JK; Bhagani S; Benhamou Y; Bruno R; Mauss S; Peters L; Puoti M; Soriano V; Tural C;
    HIV Med; 2008 Feb; 9(2):82-8. PubMed ID: 18257771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management and treatment of hepatitis C viral infection: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center program and the National Hepatitis C Program office.
    ; Yee HS; Currie SL; Darling JM; Wright TL
    Am J Gastroenterol; 2006 Oct; 101(10):2360-78. PubMed ID: 17032203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic hepatitis C: an age wave of disease burden.
    McHutchison JG; Bacon BR
    Am J Manag Care; 2005 Oct; 11(10 Suppl):S286-95; quiz S307-11. PubMed ID: 16232012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Present and future therapy for hepatitis C virus.
    Cornberg M; Deterding K; Manns MP
    Expert Rev Anti Infect Ther; 2006 Oct; 4(5):781-93. PubMed ID: 17140355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Projecting future complications of chronic hepatitis C in the United States.
    Davis GL; Albright JE; Cook SF; Rosenberg DM
    Liver Transpl; 2003 Apr; 9(4):331-8. PubMed ID: 12682882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effectiveness of antiviral therapy in patients with chronic hepatitis C treated by private practice gastroenterologists].
    Hofmann WP; Bock H; Weber C; Tacke W; Pfaff R; Kihn R; Moog G; Kellner HU; Schöfer M; Frick B; Berg P; Rambow A; Friedrich-Rust M; Herrmann E; Sarrazin C; Zeuzem S
    Z Gastroenterol; 2006 Jan; 44(1):25-31. PubMed ID: 16397836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic hepatitis C and genotyping: the clinical significance of determining HCV genotypes.
    Hnatyszyn HJ
    Antivir Ther; 2005; 10(1):1-11. PubMed ID: 15751759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic hepatitis C virus management: 2000-2005 update.
    Hughes CA; Shafran SD
    Ann Pharmacother; 2006 Jan; 40(1):74-82. PubMed ID: 16368925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hazardous alcohol consumption and other barriers to antiviral treatment among hepatitis C positive people receiving opioid maintenance treatment.
    Watson B; Conigrave KM; Wallace C; Whitfield JB; Wurst F; Haber PS
    Drug Alcohol Rev; 2007 May; 26(3):231-9. PubMed ID: 17454012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The kidney transplant recipient with hepatitis C infection: pre- and posttransplantation treatment.
    Terrault NA; Adey DB
    Clin J Am Soc Nephrol; 2007 May; 2(3):563-75. PubMed ID: 17699464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Which patients with hepatitis C virus should be treated?
    Shamoun DK; Anania FA
    Semin Gastrointest Dis; 2000 Apr; 11(2):84-95. PubMed ID: 10803633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severity of liver disease predicts the development of glucose abnormalities in patients with chronic hepatitis B or C following achievement of sustained virological response to antiviral therapy.
    Chehadeh W; Al-Nakib W
    J Med Virol; 2009 Apr; 81(4):610-8. PubMed ID: 19235842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of chronic hepatitis C.
    Lo Re V; Kostman JR
    Postgrad Med J; 2005 Jun; 81(956):376-82. PubMed ID: 15937203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid virologic response: a new milestone in the management of chronic hepatitis C.
    Poordad F; Reddy KR; Martin P
    Clin Infect Dis; 2008 Jan; 46(1):78-84. PubMed ID: 18171217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A general approach to the management of chronic hepatitis C.
    Dove LM
    Gastroenterol Clin North Am; 2004 Sep; 33(3):463-77, vii. PubMed ID: 15324938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of hepatocellular carcinoma complicating chronic hepatitis C.
    Ueno Y; Sollano JD; Farrell GC
    J Gastroenterol Hepatol; 2009 Apr; 24(4):531-6. PubMed ID: 19368633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.